Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9.
Liang L, Xu WY, Shen A, Cen HY, Chen ZJ, Tan L, Zhang LM, Zhang Y, Fu JJ, Qin AP, Lei XP, Li SP, Qin YY, Huang JH, Yu XY.
Liang L, et al. Among authors: shen a.
Acta Pharmacol Sin. 2022 Nov;43(11):2946-2955. doi: 10.1038/s41401-022-00893-8. Epub 2022 Apr 6.
Acta Pharmacol Sin. 2022.
PMID: 35388129
Free PMC article.